109 related articles for article (PubMed ID: 37316362)
1. The impact of postoperative complications on oncological outcomes of liver transplantation for hepatocellular carcinoma: A competing risk analysis.
Incarbone N; De Carlis R; Centonze L; Bernasconi DP; Valsecchi MG; Lauterio A; De Carlis L
Dig Liver Dis; 2023 Dec; 55(12):1690-1698. PubMed ID: 37316362
[TBL] [Abstract][Full Text] [Related]
2. Post-transplant infection improves outcome of hepatocellular carcinoma patients after orthotopic liver transplantation.
Chao JS; Zhao SL; Ou-Yang SW; Qian YB; Liu AQ; Tang HM; Zhong L; Peng ZH; Xu JM; Sun HC
World J Gastroenterol; 2019 Oct; 25(37):5630-5640. PubMed ID: 31602163
[TBL] [Abstract][Full Text] [Related]
3. Including mRECIST in the Metroticket 2.0 criteria improves prediction of hepatocellular carcinoma-related death after liver transplant.
Cucchetti A; Serenari M; Sposito C; Di Sandro S; Mosconi C; Vicentin I; Garanzini E; Mazzaferro V; De Carlis L; Golfieri R; Spreafico C; Vanzulli A; Buscemi V; Ravaioli M; Ercolani G; Pinna AD; Cescon M
J Hepatol; 2020 Aug; 73(2):342-348. PubMed ID: 32201284
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of risk factors of tumor recurrence after liver transplantation for HBV-related hepatocellular carcinoma patients].
Li Z; Mao YG; Yu C; Gao J; Zhu JY
Zhonghua Gan Zang Bing Za Zhi; 2018 Feb; 26(2):98-101. PubMed ID: 29804374
[No Abstract] [Full Text] [Related]
5. Neutrophil-lymphocyte ratio predicts the prognosis of patients with hepatocellular carcinoma after liver transplantation.
Xiao GQ; Liu C; Liu DL; Yang JY; Yan LN
World J Gastroenterol; 2013 Dec; 19(45):8398-407. PubMed ID: 24363533
[TBL] [Abstract][Full Text] [Related]
6. Differences in Posttransplant Hepatocellular Carcinoma Recurrence by Etiology of Liver Disease.
Mahmud N; Shaked A; Olthoff KM; Goldberg DS
Liver Transpl; 2019 Mar; 25(3):388-398. PubMed ID: 30362249
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation.
Choi HJ; Kim DG; Na GH; Han JH; Hong TH; You YK
World J Gastroenterol; 2013 Aug; 19(29):4737-44. PubMed ID: 23922471
[TBL] [Abstract][Full Text] [Related]
8. Shadows Behind Using Simple Risk Models in Selection of Hepatocellular Carcinoma Patients for Liver Transplantation.
Grąt M; Stypułkowski J; Morawski M; Wronka KM; Wasilewicz M; Lewandowski Z; Grąt K; Wójcik Z; Patkowski W; Zieniewicz K
Ann Surg; 2020 Jun; 271(6):1124-1131. PubMed ID: 30601254
[TBL] [Abstract][Full Text] [Related]
9. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
[TBL] [Abstract][Full Text] [Related]
10. Related Factors of Hepatocellular Carcinoma Recurrence Associated With Hyperglycemia After Liver Transplantation.
Zheng Y; Cai Q; Peng L; Sun S; Wang S; Zhou J
Transplant Proc; 2021; 53(1):177-192. PubMed ID: 33272654
[TBL] [Abstract][Full Text] [Related]
11. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
[TBL] [Abstract][Full Text] [Related]
12. Prognostic implication of early posttransplant hypercholesterolemia in liver transplantation for patients with hepatocellular carcinoma.
Wei RL; Fan GH; Zhang CZ; Chen KC; Zhang WH; Li CB; Dong SY; Chen JL; Ling SB; Zheng SS; Xu X
Hepatobiliary Pancreat Dis Int; 2023 Jun; 22(3):228-238. PubMed ID: 35613994
[TBL] [Abstract][Full Text] [Related]
13. Benefit of Treating Hepatocellular Carcinoma Recurrence after Liver Transplantation and Analysis of Prognostic Factors for Survival in a Large Euro-American Series.
Sapisochin G; Goldaracena N; Astete S; Laurence JM; Davidson D; Rafael E; Castells L; Sandroussi C; Bilbao I; Dopazo C; Grant DR; Lázaro JL; Caralt M; Ghanekar A; McGilvray ID; Lilly L; Cattral MS; Selzner M; Charco R; Greig PD
Ann Surg Oncol; 2015 Jul; 22(7):2286-94. PubMed ID: 25472651
[TBL] [Abstract][Full Text] [Related]
14. Liver transplantation for hepatocellular carcinoma comparing the Milan, UCSF, and Asan criteria: long-term follow-up of a Western single institutional experience.
Bonadio I; Colle I; Geerts A; Smeets P; Berardi G; Praet M; Rogiers X; de Hemptinne B; Van Vlierberghe H; Troisi RI
Clin Transplant; 2015 May; 29(5):425-33. PubMed ID: 25808782
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
[TBL] [Abstract][Full Text] [Related]
16. Salvage Versus Primary Liver Transplantation for Early Hepatocellular Carcinoma: Do Both Strategies Yield Similar Outcomes?
Bhangui P; Allard MA; Vibert E; Cherqui D; Pelletier G; Cunha AS; Guettier C; Vallee JC; Saliba F; Bismuth H; Samuel D; Castaing D; Adam R
Ann Surg; 2016 Jul; 264(1):155-63. PubMed ID: 26649581
[TBL] [Abstract][Full Text] [Related]
17. Salvage Liver Transplant versus Primary Liver Transplant for Patients with Hepatocellular Carcinoma.
Yadav DK; Chen W; Bai X; Singh A; Li G; Ma T; Yu X; Xiao Z; Huang B; Liang T
Ann Transplant; 2018 Aug; 23():524-545. PubMed ID: 30072683
[TBL] [Abstract][Full Text] [Related]
18. Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan Criteria.
Kardashian A; Florman SS; Haydel B; Ruiz RM; Klintmalm GB; Lee DD; Taner CB; Aucejo F; Tevar AD; Humar A; Verna EC; Halazun KJ; Chapman WC; Vachharajani N; Hoteit M; Levine MH; Nguyen MH; Melcher ML; Langnas AN; Carney CA; Mobley C; Ghobrial M; Amundsen B; Markmann JF; Sudan DL; Jones CM; Berumen J; Hemming AW; Hong JC; Kim J; Zimmerman MA; Nydam TL; Rana A; Kueht ML; Fishbein TM; Markovic D; Busuttil RW; Agopian VG
Hepatology; 2020 Dec; 72(6):2014-2028. PubMed ID: 32124453
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of complications after resection of early stage hepatocellular carcinoma.
Margonis GA; Sasaki K; Andreatos N; Nishioka Y; Sugawara T; Amini N; Buettner S; Hashimoto M; Shindoh J; Pawlik TM
J Surg Oncol; 2017 Jun; 115(7):791-804. PubMed ID: 28205284
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcomes of hepatocellular carcinoma that underwent chemoembolization for bridging or downstaging.
Affonso BB; Galastri FL; da Motta Leal Filho JM; Nasser F; Falsarella PM; Cavalcante RN; de Almeida MD; Felga GEG; Valle LGM; Wolosker N
World J Gastroenterol; 2019 Oct; 25(37):5687-5701. PubMed ID: 31602168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
